Gonorrhea

Microbiology & Pathogenesis - The Clap's ID

Organism: Neisseria gonorrhoeae, a Gram-negative diplococcus.
Key Features:
- Often intracellular (within neutrophils).
- Aerobic, oxidase-positive.
Major Virulence Factors (📌 POPLI):
- Pili: Attachment to mucosa; high antigenic variation.
- Opa proteins: Adhesion, invasion into host cells; antigenic variation.
- Por proteins (Porins): Outer membrane channels; prevent phagolysosome fusion.
- LOS (Lipooligosaccharide): Endotoxin; triggers inflammation, tissue damage.
- IgA protease: Cleaves IgA1, aids mucosal colonization.

⭐ Antigenic variation in pili and Opa proteins contributes to immune evasion and repeat infections.

Neisseria gonorrhoeae in neutrophils micrograph

Clinical Manifestations - Gonorrhea's Gallery

Incubation period: 2-7 days.

Urogenital (Male):
- Acute urethritis: dysuria, purulent discharge.
- Complications: epididymitis, prostatitis.
Urogenital (Female):
- Cervicitis: often asymptomatic; mucopurulent discharge.
- Urethritis.
- Risk of Pelvic Inflammatory Disease (PID).
Anorectal:
- Proctitis: often asymptomatic; features include pain, discharge, tenesmus.
Pharyngeal:
- Pharyngitis: often asymptomatic; sore throat.
Ophthalmia Neonatorum:
- Conjunctivitis in newborns: purulent discharge.
- Can lead to blindness; prophylaxis (e.g., erythromycin ointment) vital.
Disseminated Gonococcal Infection (DGI): Bacteremia.
- Two main forms:
  Syndrome Features
  Arthritis-Dermatitis Syndrome Fever, tenosynovitis, polyarthralgia, skin lesions (pustular/hemorrhagic)
  Septic Arthritis Purulent monoarthritis or oligoarthritis
- 📌 Mnemonic (Arthritis-Dermatitis): JST - Joints, Skin, Tendons.

Syndrome	Features
Arthritis-Dermatitis Syndrome	Fever, tenosynovitis, polyarthralgia, skin lesions (pustular/hemorrhagic)
Septic Arthritis	Purulent monoarthritis or oligoarthritis

⭐ Asymptomatic infection is common, especially in women (cervicitis) and pharyngeal/rectal sites, making screening crucial in high-risk populations.

Diagnostic Approach - Spotting the Culprit

Specimens: Urethral, endocervical/vaginal, urine (1st void), pharyngeal/rectal swabs, synovial fluid, blood (DGI).
Microscopy (Gram Stain): Gram-negative intracellular diplococci (GNID). >95% Sens. in symptomatic male urethritis.
Culture: Thayer-Martin (MTM) selective media (📌 VCNT: Vancomycin, Colistin, Nystatin, Trimethoprim). For antimicrobial susceptibility (AST).
NAATs (Nucleic Acid Amplification Tests): Highest Sens/Spec. Preferred. No AST.

⭐ NAATs are the diagnostic test of choice for gonorrhea due to their high sensitivity and ability to use non-invasive samples like urine, but culture is essential for antimicrobial susceptibility testing.

Diagnostic Tests Comparison:

Test	Sample(s)	Features	Use
Gram Stain	Urethral (♂), Endocervical	GNID. >95% Sens (symp. ♂ urethritis)	Rapid presumptive (symp. ♂)
Culture	Swabs, Urine	Thayer-Martin (VCNT). Allows AST.	Definitive Dx, AST
NAATs	Urine, Swabs	Highest Sens/Spec. No AST.	Preferred Dx/screening
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Start["<b>🩺 Suspected GC</b><br><span style='display:block; text-align:left; color:#555'>• N. gonorrhoeae</span><span style='display:block; text-align:left; color:#555'>• Clinical suspicion</span>"]

Assess["<b>📋 Assess Patient</b><br><span style='display:block; text-align:left; color:#555'>• Symptomatic male?</span><span style='display:block; text-align:left; color:#555'>• Urethritis signs?</span>"]

Gram["<b>🔬 Gram Stain</b><br><span style='display:block; text-align:left; color:#555'>• Look for GNID</span><span style='display:block; text-align:left; color:#555'>• >95% sensitivity</span>"]

Treat["<b>💊 Treatment</b><br><span style='display:block; text-align:left; color:#555'>• Direct therapy</span><span style='display:block; text-align:left; color:#555'>• Culture if needed</span>"]

NaatCult["<b>🔬 Diagnosis</b><br><span style='display:block; text-align:left; color:#555'>• NAAT or Culture</span><span style='display:block; text-align:left; color:#555'>• Extragenital/Asx</span>"]

NaatPref["<b>✅ NAAT Result</b><br><span style='display:block; text-align:left; color:#555'>• Preferred method</span><span style='display:block; text-align:left; color:#555'>• High Sens/Spec</span>"]

AstCult["<b>🔬 AST Culture</b><br><span style='display:block; text-align:left; color:#555'>• Susceptibility</span><span style='display:block; text-align:left; color:#555'>• Resistance check</span>"]

Start --> Assess
Assess -->|Yes| Gram
Assess -->|No/Asx| NaatCult

Gram -->|Positive| Treat
Gram -->|Neg/Equiv| NaatCult

NaatCult --> NaatPref
NaatCult -->|If AST needed| AstCult

style Start fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Assess fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Gram fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style Treat fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
style NaatCult fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style NaatPref fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252
style AstCult fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C


## Treatment & Complications - Gonorrhea's Gauntlet

*   **Antimicrobial Resistance:** A major concern; monitor local patterns.
*   **Uncomplicated Gonorrhea** (Urogenital, Rectal, Pharyngeal):
    -   **Ceftriaxone 500 mg IM** (or **1g IM** if body weight ≥150 kg) single dose.
    -   PLUS (if chlamydia not excluded): **Doxycycline 100 mg** orally BID for **7 days**.
    -   Pharyngeal: Test-of-cure (NAAT/culture) **7-14 days** post-treatment.
*   **Disseminated Gonococcal Infection (DGI):**
    -   Hospitalization.
    -   **Ceftriaxone 1g IV/IM q24h** for **7 days** (initial parenteral, then oral).
*   **Ophthalmia Neonatorum:**
    -   Treatment: **Ceftriaxone 25-50 mg/kg IV/IM** (max **125 mg**) single dose.
    -   Prophylaxis: Erythromycin 0.5% ophthalmic ointment.
*   **Partner Management:**
    -   Treat partners from last **60 days**.
    -   Abstain from sex for 7 days post-treatment (all partners).
*   **Complications:**
    -   Male: Epididymo-orchitis, infertility.
    -   Female: PID, infertility, ectopic pregnancy, Fitz-Hugh-Curtis syndrome.
*   **Prevention:** Condoms, screening, education.

> ⭐ Due to widespread antimicrobial resistance, dual therapy with ceftriaxone and doxycycline (if chlamydia not excluded) is standard for uncomplicated gonorrhea; test-of-cure is recommended for pharyngeal infections.

![Fitz-Hugh-Curtis syndrome adhesions (violin string)](https://ylbwdadhbcjolwylidja.supabase.co/storage/v1/object/public/notes/L1/Internal_Medicine_Venerology_Gonorrhea/a9e68979-8337-4df7-9d36-634e59beffe4.png)

```mermaid
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Start["<b>🩺 Gonorrhea Dx</b><br><span style='display:block; text-align:left; color:#555'>• Confirm infection</span><span style='display:block; text-align:left; color:#555'>• Identify sites</span>"]

Case["<b>📋 Select Case</b><br><span style='display:block; text-align:left; color:#555'>• Assess severity</span><span style='display:block; text-align:left; color:#555'>• Clinical type</span>"]

Uncomp["<b>💊 Uncomplicated</b><br><span style='display:block; text-align:left; color:#555'>• Ceftriaxone 500mg</span><span style='display:block; text-align:left; color:#555'>• Add Doxycycline</span>"]

DGI["<b>⚠️ Disseminated</b><br><span style='display:block; text-align:left; color:#555'>• Hospitalize pt</span><span style='display:block; text-align:left; color:#555'>• IV/IM Ceftriaxone</span>"]

Ophthalmia["<b>🔬 Ophthalmia Neon.</b><br><span style='display:block; text-align:left; color:#555'>• Ceftriaxone IM</span><span style='display:block; text-align:left; color:#555'>• Erythro ointment</span>"]

TOC["<b>👁️ Test-of-Cure</b><br><span style='display:block; text-align:left; color:#555'>• Pharyngeal check</span><span style='display:block; text-align:left; color:#555'>• Re-test 7-14d</span>"]

Partners["<b>✅ Shared Steps</b><br><span style='display:block; text-align:left; color:#555'>• Treat partners</span><span style='display:block; text-align:left; color:#555'>• 7d abstinence</span>"]

Start --> Case
Case -->|Uncomplicated| Uncomp
Case -->|Disseminated| DGI
Case -->|Neonatal| Ophthalmia

Uncomp -->|Pharyngeal| TOC
Uncomp --> Partners
DGI --> Partners
Ophthalmia -->|Mother/Partn.| Partners

style Start fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Case fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Uncomp fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
style DGI fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C
style Ophthalmia fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style TOC fill:#EEFAFF, stroke:#DAF3FF, stroke-width:1.5px, rx:12, ry:12, color:#0369A1
style Partners fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252

High‑Yield Points - ⚡ Biggest Takeaways

Neisseria gonorrhoeae (Gram-negative diplococcus) is the causative agent.

Commonest presentations: purulent urethritis in males, cervicitis (often asymptomatic) in females.

Key complications: Pelvic Inflammatory Disease (PID), epididymo-orchitis, Disseminated Gonococcal Infection (DGI) featuring arthritis-dermatitis syndrome.

Ophthalmia neonatorum is a serious neonatal infection.

NAAT is the diagnostic gold standard; Gram stain reveals intracellular diplococci.

Preferred treatment: Ceftriaxone IM (plus Azithromycin/Doxycycline for Chlamydia co-infection).

Significant concern: Increasing quinolone and cephalosporin resistance.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play

Microbiology & Pathogenesis - The Clap's ID

Organism: Neisseria gonorrhoeae, a Gram-negative diplococcus.
Key Features:
- Often intracellular (within neutrophils).
- Aerobic, oxidase-positive.
Major Virulence Factors (📌 POPLI):
- Pili: Attachment to mucosa; high antigenic variation.
- Opa proteins: Adhesion, invasion into host cells; antigenic variation.
- Por proteins (Porins): Outer membrane channels; prevent phagolysosome fusion.
- LOS (Lipooligosaccharide): Endotoxin; triggers inflammation, tissue damage.
- IgA protease: Cleaves IgA1, aids mucosal colonization.

⭐ Antigenic variation in pili and Opa proteins contributes to immune evasion and repeat infections.

Neisseria gonorrhoeae in neutrophils micrograph

Clinical Manifestations - Gonorrhea's Gallery

Incubation period: 2-7 days.

Urogenital (Male):
- Acute urethritis: dysuria, purulent discharge.
- Complications: epididymitis, prostatitis.
Urogenital (Female):
- Cervicitis: often asymptomatic; mucopurulent discharge.
- Urethritis.
- Risk of Pelvic Inflammatory Disease (PID).
Anorectal:
- Proctitis: often asymptomatic; features include pain, discharge, tenesmus.
Pharyngeal:
- Pharyngitis: often asymptomatic; sore throat.
Ophthalmia Neonatorum:
- Conjunctivitis in newborns: purulent discharge.
- Can lead to blindness; prophylaxis (e.g., erythromycin ointment) vital.
Disseminated Gonococcal Infection (DGI): Bacteremia.
- Two main forms:
  Syndrome Features
  Arthritis-Dermatitis Syndrome Fever, tenosynovitis, polyarthralgia, skin lesions (pustular/hemorrhagic)
  Septic Arthritis Purulent monoarthritis or oligoarthritis
- 📌 Mnemonic (Arthritis-Dermatitis): JST - Joints, Skin, Tendons.

Syndrome	Features
Arthritis-Dermatitis Syndrome	Fever, tenosynovitis, polyarthralgia, skin lesions (pustular/hemorrhagic)
Septic Arthritis	Purulent monoarthritis or oligoarthritis

⭐ Asymptomatic infection is common, especially in women (cervicitis) and pharyngeal/rectal sites, making screening crucial in high-risk populations.

Diagnostic Approach - Spotting the Culprit

Specimens: Urethral, endocervical/vaginal, urine (1st void), pharyngeal/rectal swabs, synovial fluid, blood (DGI).
Microscopy (Gram Stain): Gram-negative intracellular diplococci (GNID). >95% Sens. in symptomatic male urethritis.
Culture: Thayer-Martin (MTM) selective media (📌 VCNT: Vancomycin, Colistin, Nystatin, Trimethoprim). For antimicrobial susceptibility (AST).
NAATs (Nucleic Acid Amplification Tests): Highest Sens/Spec. Preferred. No AST.

⭐ NAATs are the diagnostic test of choice for gonorrhea due to their high sensitivity and ability to use non-invasive samples like urine, but culture is essential for antimicrobial susceptibility testing.

Diagnostic Tests Comparison:

Test	Sample(s)	Features	Use
Gram Stain	Urethral (♂), Endocervical	GNID. >95% Sens (symp. ♂ urethritis)	Rapid presumptive (symp. ♂)
Culture	Swabs, Urine	Thayer-Martin (VCNT). Allows AST.	Definitive Dx, AST
NAATs	Urine, Swabs	Highest Sens/Spec. No AST.	Preferred Dx/screening
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Start["<b>🩺 Suspected GC</b><br><span style='display:block; text-align:left; color:#555'>• N. gonorrhoeae</span><span style='display:block; text-align:left; color:#555'>• Clinical suspicion</span>"]

Assess["<b>📋 Assess Patient</b><br><span style='display:block; text-align:left; color:#555'>• Symptomatic male?</span><span style='display:block; text-align:left; color:#555'>• Urethritis signs?</span>"]

Gram["<b>🔬 Gram Stain</b><br><span style='display:block; text-align:left; color:#555'>• Look for GNID</span><span style='display:block; text-align:left; color:#555'>• >95% sensitivity</span>"]

Treat["<b>💊 Treatment</b><br><span style='display:block; text-align:left; color:#555'>• Direct therapy</span><span style='display:block; text-align:left; color:#555'>• Culture if needed</span>"]

NaatCult["<b>🔬 Diagnosis</b><br><span style='display:block; text-align:left; color:#555'>• NAAT or Culture</span><span style='display:block; text-align:left; color:#555'>• Extragenital/Asx</span>"]

NaatPref["<b>✅ NAAT Result</b><br><span style='display:block; text-align:left; color:#555'>• Preferred method</span><span style='display:block; text-align:left; color:#555'>• High Sens/Spec</span>"]

AstCult["<b>🔬 AST Culture</b><br><span style='display:block; text-align:left; color:#555'>• Susceptibility</span><span style='display:block; text-align:left; color:#555'>• Resistance check</span>"]

Start --> Assess
Assess -->|Yes| Gram
Assess -->|No/Asx| NaatCult

Gram -->|Positive| Treat
Gram -->|Neg/Equiv| NaatCult

NaatCult --> NaatPref
NaatCult -->|If AST needed| AstCult

style Start fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Assess fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Gram fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style Treat fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
style NaatCult fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style NaatPref fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252
style AstCult fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C


## Treatment & Complications - Gonorrhea's Gauntlet

*   **Antimicrobial Resistance:** A major concern; monitor local patterns.
*   **Uncomplicated Gonorrhea** (Urogenital, Rectal, Pharyngeal):
    -   **Ceftriaxone 500 mg IM** (or **1g IM** if body weight ≥150 kg) single dose.
    -   PLUS (if chlamydia not excluded): **Doxycycline 100 mg** orally BID for **7 days**.
    -   Pharyngeal: Test-of-cure (NAAT/culture) **7-14 days** post-treatment.
*   **Disseminated Gonococcal Infection (DGI):**
    -   Hospitalization.
    -   **Ceftriaxone 1g IV/IM q24h** for **7 days** (initial parenteral, then oral).
*   **Ophthalmia Neonatorum:**
    -   Treatment: **Ceftriaxone 25-50 mg/kg IV/IM** (max **125 mg**) single dose.
    -   Prophylaxis: Erythromycin 0.5% ophthalmic ointment.
*   **Partner Management:**
    -   Treat partners from last **60 days**.
    -   Abstain from sex for 7 days post-treatment (all partners).
*   **Complications:**
    -   Male: Epididymo-orchitis, infertility.
    -   Female: PID, infertility, ectopic pregnancy, Fitz-Hugh-Curtis syndrome.
*   **Prevention:** Condoms, screening, education.

> ⭐ Due to widespread antimicrobial resistance, dual therapy with ceftriaxone and doxycycline (if chlamydia not excluded) is standard for uncomplicated gonorrhea; test-of-cure is recommended for pharyngeal infections.

![Fitz-Hugh-Curtis syndrome adhesions (violin string)](https://ylbwdadhbcjolwylidja.supabase.co/storage/v1/object/public/notes/L1/Internal_Medicine_Venerology_Gonorrhea/a9e68979-8337-4df7-9d36-634e59beffe4.png)

```mermaid
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD

Start["<b>🩺 Gonorrhea Dx</b><br><span style='display:block; text-align:left; color:#555'>• Confirm infection</span><span style='display:block; text-align:left; color:#555'>• Identify sites</span>"]

Case["<b>📋 Select Case</b><br><span style='display:block; text-align:left; color:#555'>• Assess severity</span><span style='display:block; text-align:left; color:#555'>• Clinical type</span>"]

Uncomp["<b>💊 Uncomplicated</b><br><span style='display:block; text-align:left; color:#555'>• Ceftriaxone 500mg</span><span style='display:block; text-align:left; color:#555'>• Add Doxycycline</span>"]

DGI["<b>⚠️ Disseminated</b><br><span style='display:block; text-align:left; color:#555'>• Hospitalize pt</span><span style='display:block; text-align:left; color:#555'>• IV/IM Ceftriaxone</span>"]

Ophthalmia["<b>🔬 Ophthalmia Neon.</b><br><span style='display:block; text-align:left; color:#555'>• Ceftriaxone IM</span><span style='display:block; text-align:left; color:#555'>• Erythro ointment</span>"]

TOC["<b>👁️ Test-of-Cure</b><br><span style='display:block; text-align:left; color:#555'>• Pharyngeal check</span><span style='display:block; text-align:left; color:#555'>• Re-test 7-14d</span>"]

Partners["<b>✅ Shared Steps</b><br><span style='display:block; text-align:left; color:#555'>• Treat partners</span><span style='display:block; text-align:left; color:#555'>• 7d abstinence</span>"]

Start --> Case
Case -->|Uncomplicated| Uncomp
Case -->|Disseminated| DGI
Case -->|Neonatal| Ophthalmia

Uncomp -->|Pharyngeal| TOC
Uncomp --> Partners
DGI --> Partners
Ophthalmia -->|Mother/Partn.| Partners

style Start fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Case fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Uncomp fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
style DGI fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C
style Ophthalmia fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style TOC fill:#EEFAFF, stroke:#DAF3FF, stroke-width:1.5px, rx:12, ry:12, color:#0369A1
style Partners fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252

High‑Yield Points - ⚡ Biggest Takeaways

Neisseria gonorrhoeae (Gram-negative diplococcus) is the causative agent.

Commonest presentations: purulent urethritis in males, cervicitis (often asymptomatic) in females.

Key complications: Pelvic Inflammatory Disease (PID), epididymo-orchitis, Disseminated Gonococcal Infection (DGI) featuring arthritis-dermatitis syndrome.

Ophthalmia neonatorum is a serious neonatal infection.

NAAT is the diagnostic gold standard; Gram stain reveals intracellular diplococci.

Preferred treatment: Ceftriaxone IM (plus Azithromycin/Doxycycline for Chlamydia co-infection).

Significant concern: Increasing quinolone and cephalosporin resistance.

Gonorrhea Indian Medical PG Practice Questions and MCQs

Practice Indian Medical PG questions for Gonorrhea. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.

Gonorrhea Indian Medical PG Question 1: What structure of Neisseria gonorrhoeae is primarily responsible for its pathogenicity?

A. Pili (Correct Answer)
B. Capsule
C. Flagella
D. Endotoxin

Gonorrhea Explanation: ***Pili*** - **Pili** enable *Neisseria gonorrhoeae* to adhere to host epithelial cells, which is crucial for colonization and initiation of infection. - They also facilitate evasion of the host immune response by undergoing **antigenic variation**, making it difficult for the immune system to recognize and eliminate the bacteria. *Capsule* - While some bacterial species use a **capsule** for immune evasion and adherence, *Neisseria gonorrhoeae* does not typically possess a prominent capsule. - Its pathogenicity is primarily attributed to other factors like pili and outer membrane proteins. *Flagella* - **Flagella** provide motility to bacteria, but *Neisseria gonorrhoeae* is a non-motile bacterium and does not possess flagella. - Therefore, flagella do not contribute to its pathogenicity. *Endotoxin* - **Endotoxin** (specifically **lipooligosaccharide, LOS**, in *Neisseria*) does contribute to the pathology of gonococcal infections by causing inflammation and tissue damage. - However, the primary factor for initial adherence and colonization, which is essential for establishing infection, is the **pili**.

Gonorrhea Indian Medical PG Question 2: Which of the following is NOT a virulence factor of Cryptococcus?

A. Polysaccharide capsule
B. Ability to make melanin
C. Production of protease (Correct Answer)
D. Urease production

Gonorrhea Explanation: ***Production of protease*** - While *Cryptococcus neoformans* can produce some proteolytic enzymes, **protease production is not considered a major or classical virulence factor** in standard medical microbiology literature. - Unlike the other three factors listed, proteases are not prominently featured as key virulence mechanisms in *Cryptococcus* pathogenesis for medical education purposes. - The primary virulence factors emphasized for *Cryptococcus* are the capsule, melanin, and urease. *Polysaccharide capsule* - The **polysaccharide capsule** is the MOST important virulence factor, protecting the yeast from phagocytosis and immune clearance. - It interferes with antigen presentation, antibody binding, and complement activation, making it crucial for survival in the host. *Ability to make melanin* - **Melanin production** protects *Cryptococcus* from oxidative stress, free radicals, UV radiation, and antifungal agents. - It contributes to survival in macrophages and persistence in the central nervous system. *Urease production* - **Urease production** enables *Cryptococcus* to cross the blood-brain barrier and colonize the central nervous system. - Urease hydrolyzes urea into ammonia, causing local alkalinization that facilitates CNS invasion and contributes to meningoencephalitis.

Gonorrhea Indian Medical PG Question 3: A 20-year-old man presents with dysuria, urgency, and urethral discharge. Physical examination shows suppurative urethritis, with redness and swelling at the urethral meatus. Which of the following is the most likely etiology of urethritis in this patient?

A. Haemophilus ducreyi
B. Chlamydia trachomatis
C. Ureaplasma urealyticum
D. Neisseria gonorrhoeae (Correct Answer)

Gonorrhea Explanation: ***Neisseria gonorrhoeae*** - The presentation of **dysuria, urgency, urethral discharge**, and **suppurative urethritis** (purulent discharge with redness and swelling) is highly characteristic of **gonococcal urethritis** [1]. - **Gonorrhea** is a common cause of sexually transmitted urethritis, especially with prominent inflammatory signs [1]. *Haemophilus ducreyi* - This bacterium is the causative agent of **chancroid**, which typically presents as painful genital ulcers with regional lymphadenopathy. - It does not cause urethritis with significant urethral discharge as described. *Chlamydia trachomatis* - While *Chlamydia trachomatis* is a common cause of urethritis, it typically causes **non-gonococcal urethritis (NGU)**, which is often less symptomatic and may present with a thinner, mucoid discharge [1]. - The **suppurative (purulent) nature** of the discharge described points more strongly towards gonorrhea [1]. *Ureaplasma urealyticum* - *Ureaplasma urealyticum* is a known cause of **non-chlamydial, non-gonococcal urethritis**, similarly to *Chlamydia* [1]. - However, its presentation is generally milder and less suppurative than that caused by *Neisseria gonorrhoeae* [1].

Gonorrhea Indian Medical PG Question 4: A 24-year-old woman presents with vaginal discharge, dysuria, and lower abdominal pain. On examination, there is cervical motion tenderness and mucopurulent cervical discharge. What is the diagnostic test of choice?

A. Culture on modified Thayer-Martin medium
B. Wet mount examination
C. Gram stain of cervical secretions
D. Nucleic acid amplification test (NAAT) (Correct Answer)

Gonorrhea Explanation: ***Nucleic acid amplification test (NAAT)*** - NAATs are the **most sensitive and specific** tests for detecting *Chlamydia trachomatis* and *Neisseria gonorrhoeae*, common causes of cervicitis, which is suggested by the patient's symptoms (vaginal discharge, dysuria, lower abdominal pain, cervical motion tenderness, mucopurulent discharge). - They can be performed on **non-invasive samples** (e.g., urine, vaginal swabs), making them convenient and preferred for screening and diagnosis. *Culture on modified Thayer-Martin medium* - While **gonococcal culture** on modified Thayer-Martin medium is a specific test, it has **lower sensitivity** compared to NAATs and is more labor-intensive. - It is often reserved for cases where **antibiotic resistance testing** is needed or when NAATs are unavailable. *Wet mount examination* - A **wet mount** can identify motile trichomonads (*Trichomonas vaginalis*), yeast (candidiasis), and clue cells (bacterial vaginosis). - However, it **does not diagnose cervicitis** caused by *Chlamydia* or *Gonorrhea*, which are strongly suspected given the cervical motion tenderness and mucopurulent discharge. *Gram stain of cervical secretions* - A **Gram stain** can identify gram-negative intracellular diplococci suggestive of **gonorrhea**, but its **sensitivity is variable** in women, especially in asymptomatic cases, and it cannot detect chlamydia. - It is **insufficient for definitive diagnosis** of chlamydial infection or as a sole diagnostic tool for gonorrhea due to its lower sensitivity compared to NAATs.

Gonorrhea Indian Medical PG Question 5: A 25-year-old male presents with a burning sensation during urination and purulent discharge from the penis, which started 5 days ago. He reports unprotected sexual intercourse with a new partner two weeks ago. Examination reveals an erythematous urethral meatus with noticeable purulent discharge. A Gram stain of the discharge reveals intracellular gramnegative diplococci. The patient is otherwise healthy with no known drug allergies. What is the most appropriate treatment for this patient?

A. Metronidazole 500 mg orally twice daily for 7 days
B. Doxycycline 100 mg orally twice daily for 7 days
C. Ceftriaxone 500 mg intramuscularly
D. Cefixime 400 mg orally once (Correct Answer)

Gonorrhea Explanation: ***Cefixime 400 mg orally once*** - This patient presents with symptoms and a Gram stain consistent with **gonococcal urethritis** (**intracellular gram-negative diplococci**) [1]. - Oral cefixime is an alternative first-line option for **uncomplicated gonococcal infections** when intramuscular ceftriaxone is not feasible or available [1]. *Metronidazole 500 mg orally twice daily for 7 days* - **Metronidazole** is primarily used to treat **anaerobic bacterial infections** and **parasitic infections** (e.g., trichomoniasis, bacterial vaginosis). - It is not effective against **Neisseria gonorrhoeae**, the causative agent of this patient's condition. *Doxycycline 100 mg orally twice daily for 7 days* - **Doxycycline** is the treatment of choice for **Chlamydia trachomatis infections** and is often co-administered empirically with gonorrhea treatment due to high rates of co-infection [1]. - While it addresses potential chlamydial co-infection, it is not the primary treatment for **gonococcal urethritis** itself. *Ceftriaxone 500 mg intramuscularly* - **Ceftriaxone 500 mg IM (or 1 gram in some guidelines)** is the **preferred first-line treatment for uncomplicated gonococcal infections** due to its high efficacy and single-dose administration [1]. - While an excellent choice, the question asks for the *most appropriate* given the options, and oral cefixime is an acceptable alternative, especially in scenarios where IM injections are impractical.

Gonorrhea Indian Medical PG Question 6: A 25-year-old male presents with purulent urethral discharge and dysuria for 3 days. Gram stain shows intracellular gram-negative diplococci. What is the most appropriate empirical treatment regimen according to current CDC guidelines?

A. Ceftriaxone 500mg IM single dose + Azithromycin 1g oral single dose (Correct Answer)
B. Azithromycin 2g oral single dose
C. Doxycycline 100mg oral twice daily for 7 days
D. Ceftriaxone 1g IM single dose

Gonorrhea Explanation: ***Ceftriaxone 500mg IM single dose + Azithromycin 1g oral single dose*** - This regimen is the recommended empirical treatment for **uncomplicated gonococcal infections** according to current CDC guidelines, covering both *N. gonorrhoeae* and potential co-infection with *C. trachomatis*. [1] - The **intracellular gram-negative diplococci** on Gram stain are highly suggestive of **Neisseria gonorrhoeae**, and the addition of azithromycin addresses potential **chlamydial co-infection**. [1] *Azithromycin 2g oral single dose* - While azithromycin is used to treat **Chlamydia**, a 2g dose alone as monotherapy is not recommended for suspected gonococcal urethritis due to increased **resistance concerns** and lack of optimal efficacy against *N. gonorrhoeae*. - This regimen would not adequately cover **gonorrhea**, especially given the evidence of gram-negative diplococci. *Doxycycline 100mg oral twice daily for 7 days* - Doxycycline is the primary treatment for **chlamydial infections**, but it is **not effective** as monotherapy for **gonorrhea**. - Using doxycycline alone for suspected gonococcal urethritis would result in **treatment failure** for the likely gonococcal infection. *Ceftriaxone 1g IM single dose* - **Ceftriaxone** is the cornerstone of gonorrhea treatment, but the recommended dose for uncomplicated infection is **500mg IM**. [1] A 1g dose is typically reserved for severe or disseminated cases. - More importantly, **monotherapy with ceftriaxone** is generally not recommended due to the high prevalence of **chlamydial co-infection**, which would not be treated with ceftriaxone alone.

Gonorrhea Indian Medical PG Question 7: A patient with multiple sexual exposures is diagnosed with gonorrhea. What is the appropriate treatment?

A. Acyclovir
B. Cefixime
C. Doxycycline
D. Ceftriaxone (Correct Answer)

Gonorrhea Explanation: ***Ceftriaxone*** - **Ceftriaxone** is the **first-line recommended treatment** for uncomplicated gonorrhea according to **CDC and WHO guidelines**. - Administered as a **single intramuscular injection (500 mg IM)**, it provides highly effective coverage against *Neisseria gonorrhoeae* with minimal resistance. - It works by inhibiting bacterial cell wall synthesis, and is the **gold standard therapy** for gonorrhea treatment. - For patients with multiple sexual exposures, empiric treatment for co-infection with *Chlamydia trachomatis* (doxycycline) should also be considered. *Cefixime* - **Cefixime** was previously used as an oral alternative but is **no longer recommended** as first-line therapy due to **increasing resistance** of *N. gonorrhoeae*. - The CDC removed cefixime from recommended regimens due to **inferior efficacy** compared to ceftriaxone and concerns about treatment failures. - While it is an oral cephalosporin, it is **not appropriate first-line therapy** for gonorrhea. *Doxycycline* - **Doxycycline** is commonly used to treat **co-infection with *Chlamydia trachomatis***, which frequently occurs alongside gonorrhea. - The typical regimen is **100 mg twice daily for 7 days** as adjunctive therapy. - However, doxycycline is **not effective as monotherapy for gonorrhea** and should not be used alone to treat *N. gonorrhoeae* infection. *Acyclovir* - **Acyclovir** is an **antiviral medication** used to treat **herpes simplex virus (HSV)** infections. - It works by inhibiting viral DNA replication and has **no activity against bacterial infections** like gonorrhea. - It would be completely ineffective against *Neisseria gonorrhoeae*.

Gonorrhea Indian Medical PG Question 8: Which of the following statements about lymphogranuloma venereum (LGV) is true?

A. Primary genital ulcer is always painless
B. Rarely leads to proctocolitis
C. Caused by C. trachomatis serovars L1, L2, L3 (Correct Answer)
D. Groove sign is pathognomonic

Gonorrhea Explanation: Caused by C. trachomatis serovars L1, L2, L3 - Lymphogranuloma venereum (LGV) is specifically caused by **invasive serovars** L1, L2, and L3 of *Chlamydia trachomatis*. [1] - These serovars differ from the non-invasive serovars (A-K) that cause **genital chlamydial infections** and trachoma, as they are capable of systemic dissemination. *Primary genital ulcer is always painless* - The primary lesion of LGV, often a **papule or shallow ulcer**, appears at the site of inoculation and is typically **painless and transient**, often going unnoticed. [1] - While generally painless, in some cases, it can become **ulcerated and painful**, particularly if superinfected. *Rarely leads to proctocolitis* - **Proctocolitis** is a common manifestation of LGV, particularly in individuals engaging in receptive anal intercourse, due to direct lymphatic spread from the rectum. [1] - It can cause severe symptoms such as **rectal pain, discharge, tenesmus**, and **constipation**, progressing to fibrosis and strictures. [1] *Groove sign is pathognomonic* - The **"groove sign"**, characterized by visible depression between swollen inguinal and femoral lymph nodes, is highly suggestive of LGV but is **not pathognomonic** as it can occur in other conditions causing massive regional lymphadenopathy. - This sign indicates extensive involvement of both inguinal and femoral lymph node chains, a common feature of advanced LGV. [1]

Gonorrhea Indian Medical PG Question 9: Which STI has the highest rates of antibiotic resistance?

A. Chancroid
B. Donovanosis
C. Gonorrhea (Correct Answer)
D. Syphilis

Gonorrhea Explanation: ***Gonorrhea*** - *Neisseria gonorrhoeae* has progressively become resistant to many classes of antibiotics, including **sulfonamides, penicillin, tetracycline, macrolides, fluoroquinolones, and early cephalosporins.** [1] - **Emergence of resistance** is largely due to the organism's unique ability to acquire resistance genes and acquire genetic mutations, coupled with a high mutation rate, making it a significant public health concern. [1] *Chancroid* - Caused by **_Haemophilus ducreyi_**, which typically responds well to macrolides (e.g., azithromycin) or cephalosporins (e.g., ceftriaxone). - While resistance can occur, it is **not as widespread or severe** as with *Neisseria gonorrhoeae*. *Donovanosis* - Caused by **_Klebsiella granulomatis_**, which is generally treatable with macrolides like azithromycin or doxycycline. - **Antibiotic resistance is relatively uncommon** and does not pose a major clinical challenge. *Syphilis* - Caused by **_Treponema pallidum_**, which remains highly susceptible to penicillin, the primary treatment. - While **penicillin allergies** necessitate alternative treatments, true antibiotic resistance in *T. pallidum* is rare and has **not significantly impacted treatment efficacy**.

Gonorrhea Indian Medical PG Question 10: Which statement about the CDC recommendation for gonorrhea treatment is MOST accurate?

A. Spectinomycin is the recommended alternative for cephalosporin allergy
B. Fluoroquinolones remain first-line for uncomplicated infection
C. Monotherapy with high-dose ceftriaxone is now preferred (Correct Answer)
D. Dual therapy with ceftriaxone plus azithromycin is recommended

Gonorrhea Explanation: ***Monotherapy with high-dose ceftriaxone is now preferred*** - The CDC recently updated its recommendations, endorsing **monotherapy with a single, higher dose of ceftriaxone (500 mg IM)** for uncomplicated gonococcal infections in adults [1]. - This change reflects concerns about rising **antimicrobial resistance** and simplifies treatment strategies [1]. *Spectinomycin is the recommended alternative for cephalosporin allergy* - While spectinomycin *was* an alternative in some regions, it is **not available in the United States**, rendering it impractical for current CDC recommendations. - For patients with **cephalosporin allergy**, alternative regimens such as gentamicin plus azithromycin or azithromycin monotherapy (if susceptibility can be confirmed) are considered. *Fluoroquinolones remain first-line for uncomplicated infection* - **Fluoroquinolones are no longer recommended** for gonorrhea treatment due to widespread resistance; this recommendation was withdrawn in 2007. - The CDC specifically advises against the use of **ciprofloxacin, ofloxacin, or levofloxacin** for gonorrhea [1]. *Dual therapy with ceftriaxone plus azithromycin is recommended* - **Dual therapy with ceftriaxone and azithromycin** was recommended in the past to prevent the development of resistance. - However, due to concerns about **azithromycin resistance** and data showing the efficacy of higher-dose ceftriaxone monotherapy, the CDC has revised its guidelines [1].

More Gonorrhea Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.

Gonorrhea

On this page

Microbiology & Pathogenesis - The Clap's ID

Clinical Manifestations - Gonorrhea's Gallery

Diagnostic Approach - Spotting the Culprit

High‑Yield Points - ⚡ Biggest Takeaways

Continue reading on Oncourse

Practice Questions: Gonorrhea

Flashcards: Gonorrhea

Enjoying this lesson?